Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Long-term Prognostic Value of CaIMR in Patients With ST-segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention

NCT04984915 is registered in ClinicalTrials.gov with Zhongnan Hospital as lead sponsor.

NCT NCT04984915
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04984915 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Long-term Prognostic Value of CaIMR in Patients With ST-segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention
Lead sponsor
Zhongnan Hospital
Phase
Observational
Overall status
Unknown status
Start date
May 15, 2022
Completion date
December 1, 2023
Enrollment
400 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

caimr, prognosis, st-segment elevation myocardial infarction